IN
Insmed Inc
INSMNASDAQStock · Data from SEC EDGAR 13F · Held by 13 of 87 tracked investors
$94.96
▲ 1.75%
Market cap
$20.7B
P/E ratio
–
Tracked investors holding
13 of 87
Next earnings
–
Insmed Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
FinBoss score
48out of 100
- Valuation8
- Growth95
- Profitability5
- Quality20
- Debt100
- Stability57
In its favour
- It has more cash than debt.
Earnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 6 Aug 2026 | -0.52 | -0.69 | +24.6% |
| Mar 2026 | 7 May 2026 | -0.76 | -0.90 | +15.6% |
| Dec 2025 | 19 Feb 2026 | -1.54 | -1.07 | -43.9% |
| Sep 2025 | 30 Oct 2025 | -1.75 | -1.32 | -32.6% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart INSM
Insider purchases
last 90 days, SEC Form 4Loading insider trades…
Which investors hold this stock
13SD Stanley Druckenmiller Duquesne Family Office | 2.92% |
LA Lee Ainslie Maverick Capital | 2.03% |
RD Ray Dalio Bridgewater Associates | 0.2% |
IE Israel Englander Millennium Management | 0.08% |
SC Steven Cohen Point72 Asset Management | 0.06% |
Ns Norský státní fond Norges Bank | 0.04% |
KG Ken Griffin Citadel Advisors | 0.03% |
PT Paul Tudor Jones Tudor Investment Corp | 0.03% |
Šn Švýcarská národní banka Swiss National Bank | 0.03% |
CA Cliff Asness AQR Capital Management | 0.02% |
JG Joel Greenblatt Gotham Asset Management | 0.01% |
JY Jeff Yass Susquehanna International Group | 0.01% |
RB Ron Baron Baron Capital | 0% |
Frequently asked questions
How much is Insmed Inc (INSM) stock?
Insmed Inc shares trade at $94.96, +1.75% over the last trading day. The price is delayed.
What is the market cap of Insmed Inc?
The market cap of Insmed Inc is about $20.7B.
Which big investors hold Insmed Inc?
According to the latest 13F filings, 13 of 87 tracked investors hold Insmed Inc, for example Stanley Druckenmiller, Lee Ainslie, Ray Dalio.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.